Back to today’s briefing

Story perspectives

Study Shows Lubiprostone May Boost Kidney Function in CKD

8/30/2025

50 5

Summary

Story summary

A Tohoku University study indicates that lubiprostone may enhance kidney function in chronic kidney disease (CKD) patients.
The Phase II trial demonstrated a dose-dependent reduction in the decline of estimated glomerular filtration rate (eGFR).
Researchers plan to confirm these results in larger Phase III trials, which could change CKD treatment approaches.

1 of 1

Story summary

A Tohoku University study indicates that lubiprostone may enhance kidney function in chronic kidney disease (CKD) patients.
The Phase II trial demonstrated a dose-dependent reduction in the decline of estimated glomerular filtration rate (eGFR).
Researchers plan to confirm these results in larger Phase III trials, which could change CKD treatment approaches.